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Edited by Maurice MontalAbstract Cnidarian envenomations cause a burning-pain sensa-
tion of which the underlying mechanisms are unknown. Activa-
tion of TRPV1, a non-selective cation channel expressed in
nociceptive neurons, leads to cell depolarisation and pain. Here,
we show in vitro and in vivo evidence for desensitization-depen-
dent TRPV1 activation in cnidarian envenomations. Cnidarian
venom induced a nociceptive reactivity, comparable to capsaicin,
in laboratory rats, which could be reduced by the selective
TRPV1 antagonist, BCTC. These ﬁndings are the ﬁrst to ex-
plain at least part of the symptomology of cnidarian envenoma-
tions and provide insights into the design of more eﬀective
treatments for this global public health problem.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Desensitization1. Introduction
Increased frequency and magnitude of jellyﬁsh blooms
worldwide, together with increased occupational and recrea-
tional exposure of at-risk coastal populations to cnidarian
envenomations, underscore the need for better clinical-man-
agement tools for the treatment of such stings. Limited success
in post-envenomation pain relief has been achieved with the
empirical use of topical vinegar or hot-water immersion [1–
3]. However, currently available clinical-care modalities, based
on symptomatic treatment of resultant erythema, burning
pain, hypersensitivity and inﬂammation [4–6], generally fail
to ameliorate suﬀering. Thus, the inadequate understanding
of the principal pathophysiological pathways initiated by
envenomation has been a major impediment to developing
more targeted and eﬀective treatments. Since some members
of the TRP superfamily are known to be heat and pH sensitive
[7–12], we tested whether TRPV1 activation was responsible*Corresponding author. Fax: +32 16 323 405.
E-mail address: Jan.Tytgat@pharm.kuleuven.be (J. Tytgat).
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doi:10.1016/j.febslet.2006.09.030for the painful symptoms associated with cnidarian envenom-
ation.2. Materials and methods
2.1. Preparation of crude venom extracts
Tentacles, from Aiptasia pulchella, Cyanea capillata, Physalia physa-
lis and Chironex ﬂeckeri were cut into small pieces and suspended in
50–60 ml 10% acetic acid per 1.5–2 g of tentacles. The mixture was stir-
red overnight at room temperature with a magnetic stirrer, then centri-
fuged at 40000 · g for 1 h. Nearly all of the supernatant was recovered
by careful decantation or removal by a syringe. The supernatant was
concentrated by rotatory evaporation to about 10% of its original vol-
ume, diluted with 5–6 volumes of deionized water and freeze-dried.
Freeze-dried samples were dissolved again in ND96. Solutions were ti-
trated to pH 7.4 with NaOH.
2.2. Electrophysiological recordings
cRNA transcripts were synthesized from XbaI-linearized VR1
cDNA templates using T7 RNA polymerase (Ambion). Oocytes, har-
vested from anaesthetized female Xenopus laevis frogs as previously de-
scribed [13], were injected with 0.5–5 ng TRPV1 cRNA. Two to seven
days after injection, two-electrode voltage-clamp recording was per-
formed. Currents were measured in ND96 solution using a protocol
of 90 mV during 400 s. Tail current experiments in Fig. 3 were mea-
sured at a holding of 0 mV, test steps from 100 to +160 mV for
200 ms. The recording chamber was perfused at a rate of 2 ml min1
with a ND-96 solution containing (in mM) 96 NaCl, 2 KCl, 1.8 CaCl2,
1 MgCl2, 5 HEPES, pH 7.4. Temperature of the perfusate was kept at
22 C and controlled using a SC-20 dual in-line heater/cooler (Warner
Instruments) and pH was kept at 7.4. As previously described [7], cap-
saicin (2 lM) was used as an agonist and capsazepine (10 lM) as an
antagonist of TRPV1. Capsaicin and capsazepine were purchased from
Sigma, and anandamide from Tocris. In in vitro experiments, following
venom concentrations are used: 150 mg crude freez-dried C. capillata
venom was dissolved in 50 ml ND96; 215 mg freez-dried P. physalis
was dissolved in 50 ml ND96; 170 mg freez-dried C. ﬂeckeri venom
was dissolved in 30 ml ND96 and few hundred micrograms of crude
C. capillata venom was dissolved is 5 ml ND96. Ten milligram BmK
venom was dissolved in 40 ml ND96.
To control the expression level of the TRPV1 channels, we
always started our experiments with a ﬁrst activation of TRPV1
with 2 lM capsaicin. Application of capsaicin (or anandamide) opens
the channels. This activation gives an inward non-selective cation
current.
2.3. In vivo studies
Male Sprague Dawley rats (Harlan, Eystrup, Germany) weighing
between 270 and 310 g, were maintained in a climate-controlled envi-
ronment on a 12 h light/dark cycle at a temperature of 22 ± 1 C. All
experiments were carried out during the light phase. During housing
water and food were available ad libitum. The animals were habituated
to the experimental room for at least 1 h before the start of theblished by Elsevier B.V. All rights reserved.
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according to guidelines of the Institutional Ethical Committee for Ani-
mal Experiments and guidelines for animal research according to
IASP. In in vivo experiments, 75 mg venom was dissolved in 0.5 ml
sterile water and a dose of 40 mg/kg was injected.
The formalin test is a chemical assay of nociception. At 30 min after
sc injection of the test compound rats were given a single injection of
formaldehyde (50 ll, 1.75%) in the plantar hypodermis of the skin of
the left hind paw. Within seconds the rats started to ﬂinch the paw rap-
idly, this is the phase I response that is measured during the ﬁrst
10 min. The following phase II is measured during 50 min and repre-
sents a more tonic state. This biphasic ﬂinch behaviour in the rat fol-
lowing the formalin injection was measured in an Automated
Nociception Analyser (UC, San Diego, CA, USA). Therefore the
animal was placed in a Plexiglas cylinder mounted above a transmit-
ter/receiver coils assembly. The system detects movement of a small
metal band placed on the injected paw. A signal is generated as the
band breaks the electromagnetic ﬁeld of a loop antenna placed under-
neath the rat. The signal is processed through an algorithm that deter-
mines ﬂinch activity using amplitude, zero voltage crossing and
duration. The total number of ﬂinches observed during a selected time
period was calculated by accumulating ﬂinches of each individual ani-
mal over that time period and averaging the treatment groups. Activity
of the compound was considered when the number of ﬂinches was
lower than 40 or 600 during phases I and II, respectively.Fig. 1. Eﬀects of Cnidaria and BmK venom on TRPV1. Traces from (A) A
Physalia physalis (P.P) venom D. Cyanea capillata (C.C.) venom. (A)–(D) L
(CZP). (A)–(D) Right: Allosteric eﬀect of venom with 2 lM capsaicin. (E) Le
venom in the presence of capsaicin. (F) Allosteric eﬀect of Cyanea capillata v
independent of the order of CAP or venom administration.3. Results
We tested venom extracts (10% acetic acid tentacular ex-
tracts) of four cnidarian species (A. pulchella, C. ﬂeckeri, P.
physalis and C.capillata), representing each of the four classes
in the phylum Cnidaria (Anthozoa, Cubozoa or sea wasps,
Hydrozoa and Scyphozoa or jellyﬁshes). Although none of
the four venoms tested had any signiﬁcant eﬀect of its own
(Fig. 1A–D left), there was a clear allosteric eﬀect on the
[(n + 1) with (n > 0)] activation of the channel when the venom
was applied with capsaicin (Fig. 1A–D right). We then tested
whether the endogenous activator, anandamide [14,15] also in-
duced this eﬀect. That anandamide (10 lM) elicits the same
allosteric eﬀect (Fig. 1F) suggests future studies to further test
the in vivo interplay of serum anandamide and venom constitu-
ents at the site of envenomation. Because stings of the scorpion
Buthus martensi Karsch (BmK), a very well-studied prepara-
tion, are also accompanied by symptoms of redness and burn-
ing pain [16,17], we compared the eﬀect of crude BmK venom
under the same conditions, and found no eﬀect on TRPV1iptasia pulchella (A.P.) venom (B) Chironex ﬂeckeri (C.F.) venom (C)
eft: crude venom in the absence of capsaicin (CAP) and capsazepine
ft: Trace with lack of eﬀect of BmK venom. (E) Right: Lack of eﬀect of
enom and 10 lM anandamide (ANA). Identical results were obtained
Fig. 2. TRPV1 desensitization knocked down by Cyanea capillata venom. (A) TRPV1 current during the ﬁrst activation. The venom is added on the
peak of this activation. (B) Current during the ﬁrst activation when the venom is added just at the time when desensitization is macroscopically
visible. It can be seen that the venom quickly knocks down desensitization (see arrow). (C) Trace showing the ﬁrst and second activation of the
channel and the eﬀect of the venom when added during the second activation. Note that the venom restores exactly the desensitization-dependent
fraction of the inward current (see arrow).
Fig. 3. Voltage dependence of the open probability of TRPV1
inﬂuenced by capsaicin and capsaicin with Cyanea capillata venom
on the (n + 1) activation. Left: Voltage step currents in ctrl (h)
condition, CAP (s) and CAP with venom (). Right: Open
probability (Po) calculated by ﬁtting the tail current amplitudes in
the voltage step programme (holding 0 mV, test steps from 100 to
+160 mV, increment 10 mV). Note that there is no shift between
capsaicin and capsaicin with venom conditions.
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for cnidarian venoms. Crude venom of the green mamba
(Dendroapsis angusticeps) also did not have any eﬀect on
TRPV1 (data not shown).
To clarify the mechanism of action of the venom and to
investigate whether the observed venom eﬀects were related
to desensitization of TRPV1 [18,19], the eﬀect of the venom
at the peak current from the ﬁrst and consecutive activations
was tested. Desensitisation of TRPV1 can be described as chan-
nels becoming insensitive by repeated or continuous addition of
an agonist (e.g. capsaicin). In voltage-clamp measurements it
can be seen as smaller inward currents every application or dur-
ing the application of the agonist without addition of an antag-
onist. By applying the venom on the ﬁrst peak current, we
ensured that there was virtually no desensitization of the chan-
nel (a situation comparable to Ca2+-free condition [18,19]). If
the venom eﬀect was indeed linked to desensitization, there
should be no apparent eﬀect of the venom on the peak current.
If the venom was applied after the desensitization process had
started or on the (n + 1) activation of the TRPV1 channel, a
desensitization-dependent venom eﬀect would be expected.
The results of these experiments indicated that the venom was
indeed without apparent eﬀect during the ﬁrst activation peak
of TRPV1 (Fig. 2A). By contrast, the allosteric eﬀect in which
the desensitization-dependent component is being restored by
the venom was clearly present when the venom was applied
during the desensitization phase or at the (n + 1) activation
(Fig 2B and C). Furthermore, we investigated if the venom
could shift the TRPV1 activation curve (a frequently used trick
of TRP channels [20]) and found that the open probability (Po)
calculated by ﬁtting the tail current amplitudes was not signif-
icantly shifted along the voltage axis in the presence of capsai-
cin and venom as compared to capsaicin alone (Fig. 3). As such,
these ﬁndings clearly indicate that the venom knocks down the
desensitization of TRPV1, thus resulting in larger inward cur-
rents that would generate, in turn, the typical persistent burn-
ing-pain sensation.
To test the in vivo eﬀects of cnidarian venoms and the possi-
ble therapeutic use of TRPV1 antagonists, we recorded the
number of ﬂinches for 4 min after intraplantar injection of cap-
saicin or venom in laboratory rats. The injected dose of crude
C. capillata venom was chosen based on the number of ﬂinchesthat was comparable with the number of ﬂinches seen with
10 lg capsaicin. Fig. 4A and B show a signiﬁcant increase of
ﬂinches when compared with the response after intraplantar
injection of vehicle. To test whether a TRPV1 antagonist could
inhibit the induced nociceptive reactions, 40 mg/kg of 4-(3-tri-
ﬂuoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-triﬂu-
oromethylpyridin-2-yl)amide (BCTC), a high-aﬃnity TRPV1
antagonist [21], was injected subcutaneously 1 hour before
intraplantar injection of capsaicin or C. capillata venom. As
shown in Fig. 4A, a signiﬁcant decrease in mean pain reaction
(from 76.0 to 4.2, P < 0.05, n = 6) was observed when rats were
injected with capsaicin, following pretreatment with BCTC.
BCTC also signiﬁcantly decreased the crude venom-induced
mean number of ﬂinches (from 65.8 to 14.0, P < 0,05, n = 6)
(Fig. 4B). Injection of control vehicle did not signiﬁcantly
aﬀect the reaction after intraplantar capsaicin or venom injec-
tion. The dose needed to decrease the venom-induced number
of ﬂinches by 50% ranged between 10 and 40 mg/kg (data not
shown). The analgesic eﬀect of BCTC was maximal at a dose
Fig. 4. In vivo eﬀect of Cyanea capillata venom with and without TRPV1 antagonist. (A) Number of ﬂinches during 4-min observation period after
left-hindpaw plantar injection of capsaicin (black) and vehicle (left diagonals). Pretreatment by subcutaneous injection of 40 mg/kg BCTC (white) or
vehicle (right diagonals) and 1 h later the number of ﬂinches and bites were observed after an intraplantar injection of capsaicin (n = 6). The eﬀect of
capsaicin with BCTC was signiﬁcantly diﬀerent from the eﬀect of capsaicin alone. The BCTC vehicle did not give a signiﬁcant diﬀerence as compared
with capsaicin alone. (B) Same tests as in A. Here, the eﬀect of the venom was tested instead of capsaicin. The eﬀect of venom with BCTC was
signiﬁcantly diﬀerent from the eﬀect of venom alone. The BCTC vehicle did not give a signiﬁcant diﬀerence as compared with venom alone. In these
experiments, the serum concentrations of anandamide or other endogenous TRPV1 activators were not determined.
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doses were injected. In all cases of capsaicin and venom, there
was a baseline eﬀect of a few ﬂinches over the 4-min observa-
tion period. This indicates that other channels may also be in-
volved in the induction of the nociceptive behaviour, although
their relative contribution is presumably insigniﬁcant since the
induced pain eﬀect was reduced by 79% with BCTC, a selective
TRPV1 antagonist.
Additional rat tests in which BCTC treatment is tested on a
non-TRPV1 mediated pain behaviour (formalin test), BCTC
did not show any analgesic eﬀect. In phase I (ﬁrst 10 min
observation period) as well as in phase II (50 min observation)
there was no signiﬁcant decrease in pain response of the BCTC
treated rats. In addition, BCTC did not show any side eﬀects
such as lethargy that may aﬀect the ﬂick/lick assay.
Taken together, these in vivo results do not give 100% prove
that TRPV1 is the main pain inducing mechanism, but keeping
in mind the experiences in the empiric treatment, it gives us a
good idea in what might be happening in the in vivo situations
and they provide supportive evidence that the use of TRPV1
antagonists as analgesics in cnidarian envenomations warrants
consideration for clinical trials.4. Discussion
In conclusion, we identiﬁed TRPV1 as a key component in
the signal-transduction pathway of cnidarian envenomation.
These newfound data provide a pathophysiologic basis for
the symptomology of cnidarian stings. Although the active sub-
stance(s) in these venoms is (are) yet not fully identiﬁed (i.e.,
whether peptide or bioactive small molecule) and the precise
site of interaction still remains to be elucidated (i.e., on the
TRPV1 itself vs. the signal-transduction pathway), our discov-
ery provides important and novel insights into the design of
more eﬀective treatments for cnidarian envenomations: on the
one hand, TRPV1 blockers can possibly be used as therapeu-
tics, just as atropine is used as an antidote for organophos-phate-type intoxications on the muscarinic ACh receptor [22];
on the other hand, one might speculate that TRPV1 activators
may also be useful in the treatment of cnidarian stings as they
could counteract the venom-induced down regulation of the
desensitization. As a consequence, an inverse relationship exists
between the degree of desensitization and the size of the inward
currents. As a corollary, therefore, the burning-pain sensation
should diminish once the inward currents become smaller. It
is clear that further studies are needed to pinpoint the selectivity
ratio of cnidarian venoms between the diﬀerent members of the
large TRP family and to demonstrate if the human TRPV1
orthologue behaves in the same manner as the rat clone. None-
theless, our in vitro and in vivo experiments have shown for the
ﬁrst time a clear link between cnidarian envenomation-associ-
ated pain and TRPV1 activation via ‘knock-down’ of desensi-
tization that brings more eﬀective treatments for the
worldwide problem of cnidarian envenomations within reach.
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